Cargando…
A case of bortezomib (Velcade)–induced Stevens-Johnson syndrome confirmed by patch test
Bortezomib, a highly selective reversible inhibitor of the proteasome complex, is used to the current standard of care in the treatment of multiple myeloma. Although its most commonly reported side effects are gastrointestinal symptoms, peripheral neuropathy, neuropathic pain, and thrombocytopenia,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103010/ https://www.ncbi.nlm.nih.gov/pubmed/34007827 http://dx.doi.org/10.5415/apallergy.2021.11.e17 |